A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled "Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA ...

Researchers say that in the course of developing a new model for ovarian cancer, they've developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes, not the uterus ...

Figure 1: Hemocytometer dead cells count. Here is the bar graph showing the hemocytometer based dead cell counts for each treatment group across day 1, day 2 and day 4 (24 hours post treatment). The ...

Homologous recombination deficiency (HRD) status and response to platinum-based chemotherapy and PARP inhibitors in Chinese patients with ovarian cancer.

Cancer model systems are available to investigate disease mechanisms and to screen therapies. However, two-dimensional (2D) tissue culture models may lack realistic complexity, and may not always show ...

Biofabricated tumor microenvironments for studying colorectal cancer in vitro and in vivo. The role of anticoagulants for the primary prophylaxis of venous thromboembolism in patients with malignancy: ...

New research yields a novel method to use ultrasound to enhance machine learning's ability to accurately diagnose -- or rule out -- ovarian cancer. Although ovarian cancer is the deadliest type of ...

Plant-derived cannabinoids appear effective against ovarian cancer cells in laboratory experiments. Research from Thailand reveals that cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) ...